Patents by Inventor Lars Harder Christensen

Lars Harder Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200123213
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Applicants: ALK-ABELLÓ A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette
  • Patent number: 10556936
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Grant
    Filed: May 29, 2017
    Date of Patent: February 11, 2020
    Assignees: ALK ABELLÓ, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette
  • Publication number: 20190202875
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Application
    Filed: May 29, 2017
    Publication date: July 4, 2019
    Applicants: ALK-ABELLÓ A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette
  • Patent number: 10059751
    Abstract: The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: August 28, 2018
    Assignees: ALK-ABELLÓ A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOGY
    Inventors: Claus Lundegaard, Lars Harder Christensen, Peter Adler Wurtzen, Alessandro Sette, John Sidney, Gitte Lund, Peter Sejer Andersen
  • Publication number: 20160287696
    Abstract: The invention relates to pan pollen immunogens such as polypeptides, proteins and peptides, and methods and uses of such immunogens for modulating or relieving an immune response in a subject. For example, the immunogens can be used for treating a subject for an allergic immune response or inducing or promoting immunological tolerance to the immunogen or a pollen allergen in a subject.
    Type: Application
    Filed: November 20, 2014
    Publication date: October 6, 2016
    Applicants: La Jolla Institute For Allergy And Immunology, ALK-Abelló A/S
    Inventors: Bjoern Peters, Alessandro Sette, Jason Greenbaum, Ilka Hoof, Lars Harder Christensen
  • Publication number: 20160251403
    Abstract: The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of CM a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.
    Type: Application
    Filed: December 23, 2014
    Publication date: September 1, 2016
    Applicants: ALK-ABELLO A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Claus Lundegaard, Lars Harder Christensen, Peter Adler Wurtzen, Alessandro Sette, John Sidney, Gitte Lund